GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (OTCPK:MBCOF) » Definitions » Pretax Margin %

MBCOF (Marvel Biosciences) Pretax Margin % : % (As of Jan. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Marvel Biosciences Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Marvel Biosciences's Pre-Tax Income for the three months ended in Jan. 2025 was $-0.34 Mil. Marvel Biosciences's Revenue for the three months ended in Jan. 2025 was $0.00 Mil. Therefore, Marvel Biosciences's pretax margin for the quarter that ended in Jan. 2025 was %.

The historical rank and industry rank for Marvel Biosciences's Pretax Margin % or its related term are showing as below:


MBCOF's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -127.47
* Ranked among companies with meaningful Pretax Margin % only.

Marvel Biosciences Pretax Margin % Historical Data

The historical data trend for Marvel Biosciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences Pretax Margin % Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24
Pretax Margin %
- - - - -

Marvel Biosciences Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Marvel Biosciences's Pretax Margin %

For the Biotechnology subindustry, Marvel Biosciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marvel Biosciences's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marvel Biosciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Marvel Biosciences's Pretax Margin % falls into.


;
;

Marvel Biosciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Marvel Biosciences's Pretax Margin for the fiscal year that ended in Jul. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Jul. 2024 )/Revenue (A: Jul. 2024 )
=0/0
= %

Marvel Biosciences's Pretax Margin for the quarter that ended in Jan. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jan. 2025 )/Revenue (Q: Jan. 2025 )
=-0.338/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Marvel Biosciences  (OTCPK:MBCOF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Marvel Biosciences Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Marvel Biosciences Business Description

Traded in Other Exchanges
Address
505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.